Prevention of Intrauterine Adhesions After Hysteroscopic Metroplasty With Autocross-linked Hyaluronic Acid Gel
Primary Purpose
Intrauterine Adhesions, Septate Uterus
Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Hysteroscopic metroplasty
Autocross-linked acid hyaluronic gel
Office second look hysteroscopy
Sponsored by
About this trial
This is an interventional prevention trial for Intrauterine Adhesions
Eligibility Criteria
Inclusion Criteria:
- uterine septum
- history of ≥1 miscarriage or infertility;
- desire to have children in the future
Exclusion Criteria:
- pregnancy;
- menopause;
- precancerous state or malignancy of the reproductive organs;
- benign lesions in the myometrium of the uterine fundus (myomas or adenomyosis)
- lesions distorting the uterine cavity (submucosal myomas or intrauterine adhesions) on ultrasonography;
- withdrawal of patient consent;
- rare complex uterine congenital anomalies without an ASRM classification such as uterine septum with double cervix ;
- presence of external intercornual cleft;
- incomplete (internal fundal indentation 10 mm) or non-standardized septum resection (internal fundal indentation ,10 mm and uterine myometrial thickness .10 mm at the fundus), confirmed intraoperatively
- excessive fundal incision (uterine myometrial thickness ,6 mm at the fundus confirmed intraoperatively)
Sites / Locations
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
hysteroscopic metroplasty
Arm Description
women undergoing hysteroscopic metroplasty for uterine septum resection
Outcomes
Primary Outcome Measures
Change in Formation of intrauterine adhesions
Secondary Outcome Measures
Full Information
NCT ID
NCT02404454
First Posted
March 26, 2015
Last Updated
March 8, 2016
Sponsor
University of Cagliari
Collaborators
Università degli Studi di Sassari, Azienda Sanitaria Locale di Cagliari, Azienda Sanitaria Locale di Olbia, Azienda Sanitaria Locale di Oristano
1. Study Identification
Unique Protocol Identification Number
NCT02404454
Brief Title
Prevention of Intrauterine Adhesions After Hysteroscopic Metroplasty With Autocross-linked Hyaluronic Acid Gel
Study Type
Interventional
2. Study Status
Record Verification Date
March 2016
Overall Recruitment Status
Unknown status
Study Start Date
June 2016 (undefined)
Primary Completion Date
December 2016 (Anticipated)
Study Completion Date
March 2017 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Cagliari
Collaborators
Università degli Studi di Sassari, Azienda Sanitaria Locale di Cagliari, Azienda Sanitaria Locale di Olbia, Azienda Sanitaria Locale di Oristano
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The septate uterus is the most common structural uterine anomaly. It results from failure of the partition between the two fused Müllerian ducts to resorb;it is associated with the highest incidence of reproductive failure and with first- and second-trimester pregnancy loss and infertility.
Hysteroscopic division of the uterine septum is performed using microscissors, electrosurgery, or laser. Several studies shown significant improvement in pregnancy outcome after hysteroscopic metroplasty.
Purpose of this study is to verify the effectiveness of 5 ml, instead of 10 ml, of autocross-linked hyaluronic acid gel in the prevention of the formation of intrauterine adhesions, through second look office hysteroscopy after three months.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Intrauterine Adhesions, Septate Uterus
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
50 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
hysteroscopic metroplasty
Arm Type
Experimental
Arm Description
women undergoing hysteroscopic metroplasty for uterine septum resection
Intervention Type
Procedure
Intervention Name(s)
Hysteroscopic metroplasty
Intervention Type
Device
Intervention Name(s)
Autocross-linked acid hyaluronic gel
Intervention Description
Patients received adhesion barrier with 5 ml of autocross-linked acid hyaluronic gel
Intervention Type
Procedure
Intervention Name(s)
Office second look hysteroscopy
Intervention Description
Second-look hysteroscopy after three months
Primary Outcome Measure Information:
Title
Change in Formation of intrauterine adhesions
Time Frame
baseline (operative isteroscopy and three months
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
uterine septum
history of ≥1 miscarriage or infertility;
desire to have children in the future
Exclusion Criteria:
pregnancy;
menopause;
precancerous state or malignancy of the reproductive organs;
benign lesions in the myometrium of the uterine fundus (myomas or adenomyosis)
lesions distorting the uterine cavity (submucosal myomas or intrauterine adhesions) on ultrasonography;
withdrawal of patient consent;
rare complex uterine congenital anomalies without an ASRM classification such as uterine septum with double cervix ;
presence of external intercornual cleft;
incomplete (internal fundal indentation 10 mm) or non-standardized septum resection (internal fundal indentation ,10 mm and uterine myometrial thickness .10 mm at the fundus), confirmed intraoperatively
excessive fundal incision (uterine myometrial thickness ,6 mm at the fundus confirmed intraoperatively)
12. IPD Sharing Statement
Learn more about this trial
Prevention of Intrauterine Adhesions After Hysteroscopic Metroplasty With Autocross-linked Hyaluronic Acid Gel
We'll reach out to this number within 24 hrs